Drug Trial Radar · NCT02642562
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN
Last checked: Nov 20, 2026Latest source record: Oct 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,160
Planned (sponsor's estimate)
Start
Aug 2016
Primary completion
Aug 26, 2022
Study completion Aug 26, 2022
Sponsor
- Lead sponsor
- University of GlasgowAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- NHS Greater Glasgow and Clyde; Pharmacosmos A/S; British Heart Foundation
- First posted
- Dec 30, 2015
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will address whether the additional use of Intravenous (IV) iron on top of standard care will improve the outlook for patients with heart failure and iron deficiency. One group of participants will receive treatment with iron injections and the other group will not receive any iron injections.
Conditions
- Chronic Heart Failure
- Iron Deficiency
- Left Ventricular Systolic Dysfunction
Interventions
Ferric DerisomaltoseDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- CV mortality or hospitalisation for worsening heart failure (analysis will include first and recurrent hospitalisations)Time frame: Minimum of 3 months follow-up from last patient recruited
Locations
72 sites in 1 country. Site status is shown where the registry gives one.
Aberdeen Royal Infirmary
Aberdeen, United Kingdom
University Hospital Monklands
Airdrie, United Kingdom
Antrim Area Hospital
Antrim, United Kingdom
Wansbeck General Hospital
Ashington, United Kingdom
Barnet Hospital
Barnet, United Kingdom
Basildon University Hospital
Basildon, United Kingdom
Basingstoke and North Hampshire Hospital
Basingstoke, United Kingdom
Royal Victoria Hospital
Belfast, United Kingdom
Blackpool Victoria Hospital
Blackpool, United Kingdom
Royal Bournemouth Hospital
Bournemouth, United Kingdom
Bradford Royal Infirmary
Bradford, United Kingdom
Princess of Wales Hospital
Bridgend, United Kingdom
Royal Sussex County Hospital
Brighton, United Kingdom
Bristol Royal Infirmary
Bristol, United Kingdom
Broomfield Hospital
Chelmsford, United Kingdom
Chesterfield Royal Hospital
Chesterfield, United Kingdom
St. Richard's Hospital
Chichester, United Kingdom
University Hospital Coventry
Coventry, United Kingdom
Croydon University Hospital
Croydon, United Kingdom
Darlington Memorial Hospital
Darlington, United Kingdom
Doncaster Royal Infirmary
Doncaster, United Kingdom
Ninewells Hospital
Dundee, United Kingdom
Ulster Hospital
Dundonald, United Kingdom
Eastbourne District General Hospital
Eastbourne, United Kingdom
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Royal Devon and Exeter Hospital
Exeter, United Kingdom
Glasgow Royal Infirmary
Glasgow, United Kingdom
Golden Jubilee National Hospital
Glasgow, United Kingdom
Queen Elizabeth University Hospital
Glasgow, United Kingdom
Harefield Hospital
Harefield, United Kingdom
Wycombe General Hospital
High Wycombe, United Kingdom
Castle Hill Hospital
Hull, United Kingdom
Raigmore Hospital
Inverness, United Kingdom
West Middlesex University Hospital
Isleworth, United Kingdom
University Hospital Crosshouse
Kilmarnock, United Kingdom
Kingston Hospital
Kingston upon Thames, United Kingdom
Victoria Hospital
Kirkcaldy, United Kingdom
Forth Valley Royal Hospital
Larbert, United Kingdom
Glenfield Hospital
Leicester, United Kingdom
Aintree University Hospital
Liverpool, United Kingdom
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.